Background
==========

EV71 is a member of *Picornaviridae* family composed of a large number of small non-enveloped, positive strand RNA viruses with a genome size of approximately 7.4 kb \[[@B1],[@B2]\]. Both EV71 and coxsackievirus A16 (CVA16) belong to the human enterovirus A species, which are major causative agents causing hand, foot, and mouth disease (HFMD) in children \[[@B3]\]. However, patients infected with EV71 are liable to cause aseptic meningitis, encephalomyelitis, pulmonary edema and death \[[@B4],[@B5]\]. EV71 was first identified in 1969 in California when it was isolated from the feces of an infant suffering from encephalitis \[[@B6]\]. Subsequently, EV71 infection is widely popular in many countries and regions, such as Taiwan, Singapore, Malaysia, and Hongkong, as well as mainland China \[[@B7]-[@B11]\]. Up to now, the molecular pathogenesis of EV71 infection is still elusive.

Apoptosis is essential for the maintenance of homeostasis in the immune system, which is characterized morphologically by internucleosomal DNA cleavage, chromatin condensation, membrane blebbing, cell shrinkage, apoptotic body formation and cell death. The process may be triggered by interactions of pro-apoptotic stimuli coupled with various factors such as death receptors, mitochondrial apoptotic pathway and endoplasmic reticulum stress \[[@B12],[@B13]\]. In an attempt to prevent viral replication, dissemination or persistent infection of cells, many protective measures are actually involved in the induction of apoptosis that is the host response to curtail the reproductive cycle of the virus through premature lysis \[[@B14],[@B15]\]. In addition, the apoptosis of host cells can facilitate macrophages to phagocytose dead cells for preventing dysregulated inflammatory reactions or initiating specific immune responses in the infected host \[[@B16]\].

In order to elucidate the molecular basis of the host response to viral infection, anti-apoptotic response is essential for identifying the targets to reduce cell or tissue damage resulting from inflammatory responses. As described previously, EV71 can induce the apoptosis of human endothelial cells, T lymphocytes and nerve cells \[[@B17]-[@B19]\]. However, little information is known about the mechanisms of RD cell apoptosis by EV71 infection. In this study, PCR array was used to detect 84 genes associated with apoptosis and explore the host response at different time points after EV71-infection in RD cells as well as molecular mechanisms of apoptosis.

Methods
=======

Antibodies and chemicals
------------------------

Dulbecco\'s modified Eagle\'s medium (DMEM) and fetal bovine serum (FBS) were purchased from Thermo Scientific HyClone (UT, USA). Anti-caspase-8, -3, AKT2, JNK1/2, c-Jun and NF-κB p65 rabbit polyclonal antibodies were purchased from Signalway Antibody (Pearland, TX, USA). Rabbit polyclonal phospho-specific antibodies, including p-JNK1/2, p-AKT2, c-Jun and p-NF-κB p65 antibodies were also from Signalway Antibody. Anti-caspase-10, -7, and FasL were from Cell Signaling Technology (Beverly, MA, USA). Goat anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH), β-actin antibodies and IgG secondary horseradish peroxidase (HRP) conjugated were from Signalway Antibody.

RD cell culture and EV71 infection
----------------------------------

RD cells were purchased from CBTCCCAS (Chinese Academy of Sciences Cell Bank of Type Culture Collection) and cultured in high glucose DMEM supplemented with 10% FBS at 37°C in a humidified incubator with 5% CO~2~. When cells reached up to 90% confluence, the medium was removed and the monolayer cells were washed once with PBS. One batch of uninfected RD cells in 25 cm^2^ culture flask were used as the control, while another two batches of RD cells were infected with UV-inactivated EV71 strain CCTCC/GDV083 (ATCC VR-784) (China Center for Type Culture Collection, CCTCC) and alive EV71 strain GDV083 at an MOI of 5 in a 4 mL of virus inoculum diluted with maintenance medium. Approximately 1 × 10^6^ cells were incubated with EV71 at an MOI of 5 or as indicated and allowed to absorb for 2 h at 37°C. Unbounded viruses were removed by washing the cells with medium, and 15 mL of maintenance medium was added. Infected cells and culture supernatants were collected at different time intervals. Virus titers in both supernatant (extracellular) and cell lysate (intracellular) were determined using plaque assays, as described previously, at the designated time points \[[@B20]\].

Viability of RD cells
---------------------

The viability of RD cells was assayed using the trypan blue exclusion method. Cells were cultured with EV71 at an MOI of 5. After different incubation periods, cells were re-suspended in trypan blue solution and counted under a light microscope. RD cells without being stained by trypan blue were counted as the viable cells. The viability of RD cells was calculated through the total number of cells dividing by the number of viable cells.

Evaluation of apoptosis in RD cells by annexin V-FITC/PI binding assay
----------------------------------------------------------------------

RD cells were seeded at a density of 1 × 10^5^ cells onto pre-treated coverslips in a 6-well plate. After incubation at 37°C overnight, the cells were inoculated at an MOI of 5 with EV71 strain and UV-inactivated EV71 strain for 2 h. After absorption, the inoculum was removed, and replaced with 3 mL of maintenance medium. The cells were subjected to incubation for another 20 h, and then fixed with 3.7% paraformaldehyde for 30 min at room temperature. The coverslips were stained by annexin V- fluorescein isothiocyanate (FITC) / propidium iodide (PI) (Vector Laboratories, Burlingame, CA, USA) and observed under a fluorescence microscope. Flow cytometry was performed with Vybrant apoptosis assay kit (Molecular Probes, Eugene, OR) according to the manufacturer's instructions. A total of 2 × 10^4^ RD cells were infected with EV71 and harvested at 8 and 20 h postinfection. Following washes in cold phosphate-buffered saline (PBS) and re-suspension in 195 μL of 1× annexin-binding buffer, 5 μL annexin V- FITC and 10 μL PI were added to the cells and incubated at room temperature for 15 min. Stained cells were then analyzed by flow cytometry using FACS Canto System (BD Biosciences, San Jose, CA). Normal living cells were not stained with annexin V-FITC and PI, while cells stained with annexin V-FITC alone were defined as the early stage of apoptosis and the cells stained with both annexin V-FITC and PI were defined as the late stage of apoptosis or necrosis. Quantitative analysis was conducted by determining the percentage of stained cells among total cells.

ELISA for cytokines
-------------------

RD cells were infected with EV71 at an MOI of 5 for 2 h at 37°C. Infected RD cells were washed 2 times and cultured in DMEM medium. Culture supernatants were harvested at 0, 8, 20 and 32 h after EV71 infection. The expression levels of IL-4, IL-10 and TNF-α were measured by ELISA kits (R&D System, USA) according to the manufacturer's protocols. All experiments were repeated three times.

Total RNA preparation and PCR array
-----------------------------------

After incubation at 37°C for 8 and 20 h, both uninfected and infected RD cells were harvested for the extraction of total RNA. Total RNA was extracted by SV total RNA isolation system (Promega, Madison, WI, USA). A total of 1 mg RNA for each sample was used for reverse transcription through RT-PCR Kit (catalog\#CTB101; CT biosciences, China) on the ABI 9700 thermocycler (ABI, Foster City, CA). PCR arrays were performed with customized PCR containing pre-dispensed primers (CT biosciences, China) on the LightCycler 480 (Roche Diagnostics, Mannheim, Germany) using SYBR MasterMix ((catalog\#CTB101; CT biosciences, China). Each PCR contained 10 ng of synthesized cDNA. The thermocycler parameters were performed with an initial denaturation at 95°C for 5 min followed by 40 cycles of denaturation at 95°C for 15 s, annealing at 60°C for 15 s and extension at 72°C for 20 s. Relative changes in gene expressions were calculated using △△Ct (threshold cycle) method. The housekeeping genes such as B2M, ACTB, GAPDH, RPL27, HPRT1 and OAZ1 were used to normalize to the amount of RNA. Fold change values were calculated using the formula of 2-△△Ct.

Cell extract preparation and western blot analysis
--------------------------------------------------

EV71-infected cells (MOI=5) were harvested as indicated. The pellet was washed and lysed with a lysis buffer (2% sodium dodecyl sulfate, 35 mM *β*-mercaptoethanol, 50 mM Tris--HCl \[pH 6.8\], 1 mM phenylmethylsulfonylfluoride). Cell lysates were obtained by centrifugation at 13000 rpm and 4°C. Total protein concentrations were determined by the bicinchoninic acid protein assay kit (Pierce). Then, proteins were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to PVDF membranes (Millipore). Membranes were blocked for 2 h with 5% nonfat dry milk solution in Tris-buffered saline containing 0.1% Tween-20, which were blotted with specific primary antibodies, followed by incubation with secondary antibodies conjugated with HRP. Blots were developed with an enhanced ChemiDoc™ XRS^+^ system (Biorad, USA).

Statistical analysis
--------------------

All data were presented as the mean ± SE. Statistical analyses were performed using GraphPad Prism software (San Diego, CA). P value less than 0.05 was considered as statistical significance.

Results
=======

EV71 infection induced cytopathic effect in RD cells
----------------------------------------------------

Two batches of RD cells with three experimental models in each group were analyzed at 4, 8, 20, 32 and 48 h postinfection. Three models included uninfected control, mock-infection control with UV-inactivated EV71 strain GDV083 and EV71 strain GDV083 infection. The cell growth did not exhibit an obvious difference at 4 and 8 h postinfection. However, the viable cells revealed distinct decrease in EV71-infected model at 20, 32 and 48 h (Figure [1](#F1){ref-type="fig"}). Visible CPE was also observed in the infected cell culture (Figure [2](#F2){ref-type="fig"}). Viable cell counts for the uninfected and mock-infected controls were comparable without any potential "spillover" effects from the inoculum itself. In virus-infected cells, an obvious CPE was observed at 20 h postinfection. However, there was no significant change between mock control and uninfected control.

![**The characteristics of EV71-infected RD cell proliferation in different time points.** Control: Uninfected RD cells. Mock: Inactivated EV71-infected RD cells. EV71: EV71-infected RD cells. Viable cell count was assessed by trypan blue exclusion technique. The data were expressed as mean ± SE from 3 independent experiments. \* *P* \< 0.05 and \*\**P* \< 0.01 by two-way ANOVA.](1471-2334-12-327-1){#F1}

![**The morphology of EV71-infected RD cells.** Following the infection at 8 and 20 h in RD cells, cell morphology was examined under a light microscope (100×), and visible cell apoptosis was labeled by black arrow.](1471-2334-12-327-2){#F2}

Annexin V-FITC/PI fluorescent analysis of EV71-infected RD cells
----------------------------------------------------------------

In normal cells, the phosphatidylserine (PS) was localized mainly on the membrane surface of cytoplasmic cells. However, PS could be translocated to the outer leaflet of the membrane during apoptosis. Dying cells stained with annexin V allowed for the detection of PS exposure as an early indicator of apoptosis. RD cells were infected by EV71 on glass coverslips at 20 h, which stained with annexin V-FITC/PI and visualized under a fluorescence microscope. RD cell apoptosis or death was observed at 20 and 32 h postinfection (Figure [3](#F3){ref-type="fig"}). Meanwhile, RD cells were infected with EV71 and membrane change was measured using flow cytometry. As shown in Figure [4](#F4){ref-type="fig"}, 6.9% of RD cells showed membrane change at 8 h, and 18% at 20 h. Moreover, cell death or late apoptosis was 10.6% and 19.1% at 8 and 20 h postinfection, respectively.

![**EV71-induced apoptosis in RD cells.** Early membrane revealed an obvious change associated with apoptosis in EV71-infected RD cells. The exposure of phosphatidylserine (PS) was analyzed using FITC-labeled annexin V. Cell death was assessed with propidium iodide (PI). EV71-infected RD cells were harvested at 20 and 32 h postinfection and stained with annexin V-FITC/PI, and then observed under a fluorescence microscope (400×).](1471-2334-12-327-3){#F3}

![**Membrane changes associated with apoptosis in EV71-infected RD cells.** Control: Uninfected RD cells. EV71: EV71-infected RD cells. The exposure of phosphatidylserine (PS) was analyzed using FITC-labeled annexin V. Cell death was assessed using PI in a time course mode. EV71-infected RD cells were harvested at 8 and 20 h postinfection and cell death was evaluated by flow cytometry.](1471-2334-12-327-4){#F4}

Cytokine levels of IL-4, IL-10 and TNF-α
----------------------------------------

After EV71 infection at 0, 8, 20 and 32 h, the culture supernatants of RD cells were harvested, and then the levels of cytokines such as IL-4, IL-10 and TNF-α were detected by ELISA. The results suggested that EV71 infection could trigger RD cells to release IL-4, IL-10 and TNF-α (Figure [5](#F5){ref-type="fig"}).

![**EV71 infection activates the release of cytokines in RD cells.** The culture supernatants of control, mock and EV71-infected RD cells were harvested at 0, 8, 20 and 32 h after infection to measure the cytokines by ELISA. The data were expressed as mean ± SE of 3 independent experiments. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 by two-way ANOVA.](1471-2334-12-327-5){#F5}

PCR array of 84 apoptotic genes in RD cells during EV71 infection
-----------------------------------------------------------------

Cellular RNA was extracted and transcribed to cDNA in a 20 μL reaction mixture for 25 min at 40°C using random primers and SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer's instructions. The expression profile of 84 genes was generated. PCR amplification and melting curves were as shown in Figure [6](#F6){ref-type="fig"}. At 20 h postinfection, only 2 genes (c-Fos and IFN-β1) exhibited 2.34 and 5.22-fold increases, while 42 genes revealed a significant down-regulation. After EV71 infection at 20 h, the expression levels of 32 genes were larger than two fold based on PCR array. Particularly, the ligands of the TNF superfamily including FasL, CD40L and TNF-α were significantly up-regulated (Table [1](#T1){ref-type="table"}).

![**PCR amplification and melting curves.** Uninfected Control: **A**, **B** and **E**, **F**; amplification curves and melting curves at 8 and 20 h, respecively. EV71-infected RD cells: **C**, **D** and **G**, **H**; amplification curves and melting curves at 8 and 20 h postinfection by EV71, respecively.](1471-2334-12-327-6){#F6}

###### 

Differential apoptotic gene expressions of RD cells in response to EV71 infection at 8 and 20 h postinfection

  **Symbols**   **Description of genes**                                                                                           **EV71/control**  
  ------------- ----------------------------------------------------------------------------------------------------------------- ------------------ -------
  ACIN1         Apoptotic chromatin condensation inducer 1 (ACINUS; ACN; fSAP152)                                                       -3.17         1.33
  AIFM1         Apoptosis-inducing factor 1 (AIF; COXPD6; PDCD8)                                                                         1.03         -1.33
  AIFM2         Apoptosis-inducing factor, mitochondrion-associated, 2 (AMID; PRG3; RP11-367H5.2)                                       -3.83         -1.25
  Akt1          V-akt murine thymoma viral oncogene homolog 1 (AKT1; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA)                             -9.89         -1.13
  Akt2          V-akt murine thymoma viral oncogene homolog 2 (AKT2, PKBB; PKBBETA; PRKBB; RAC-BETA)                                    -3.36         2.66
  Akt3          V-akt murine thymoma viral oncogene homolog 3(AKT3)                                                                     -1.06         1.58
  APAF1         Apoptotic peptidase activating factor 1 (APAF-1; CED4)                                                                  -4.10         1.09
  API5          Apoptosis inhibitor 5 (AAC-11; AAC11)                                                                                   -5.41         1.06
  Bcl-2         B-cell lymphoma 2 (BCL-2)                                                                                               -1.07         -1.43
  BIRC2         Baculoviral IAP repeat-containing 2                                                                                      1.56         1.23
  BIRC3         Baculoviral IAP repeat-containing 3 (AIP1; API2; CIAP2; HAIP1; HIAP1; MALT2; MIHC; RNF49; c-IAP2)                       -1.84         3.19
  Caspase-3     Apoptosis-related cysteine peptidase 3(Casp3)                                                                            1.91         2.38
  Caspase-4     Apoptosis-related cysteine peptidase 4(Casp4)                                                                           -1.31         1.15
  Caspase-7     Apoptosis-related cysteine peptidase 7(Casp7)                                                                           -2.15         2.03
  Caspase-8     Apoptosis-related cysteine peptidase 8(Casp8)                                                                            1.87         2.17
  Caspase-9     Apoptosis-related cysteine peptidase 9(Casp9)                                                                           -4.98         -1.02
  Caspase-10    Apoptosis-related cysteine peptidase 10(Casp10)                                                                          1.25         2.16
  Caspase-12    Apoptosis-related cysteine peptidase 12 (Casp12)                                                                         1.24         1.10
  CD5           CD5 molecule                                                                                                            -2.41         4.77
  CD70          CD70 molecule                                                                                                            1.55         4.04
  CD40L         CD40 ligand                                                                                                             -2.51         5.44
  CD24          CD24 molecule                                                                                                            1.53         2.98
  CD27          CD27 molecule                                                                                                           -2.37         1.71
  c-Fos         c-fos proto-oncogene                                                                                                     2.34         3.23
  c-Jun         c-Jun proto-oncogene                                                                                                     1.69         5.52
  CIDEA         Cell death-inducing DFFA-like effector a                                                                                -1.32         -1.58
  CIDEB         Cell death-inducing DFFA-like effector b                                                                                -2.67         2.98
  DAPK1         Death-associated protein kinase 1                                                                                       -2.80         1.24
  DAPK2         Death-associated protein kinase 2                                                                                       -1.81         1.32
  DAPK3         Death-associated protein kinase 3 (ZIP; ZIPK)                                                                           -10.17        2.06
  DFFA          DNA fragmentation factor subunit alpha (DFF-45; DFF1; ICAD)                                                             -2.09         -1.14
  E2F1          Transcription factor E2F1 (RBAP1; RBBP3; RBP3)                                                                          -3.99         -1.17
  E2F2          Transcription factor E2F2                                                                                               -1.64         1.55
  EGFR          Epidermal growth factor receptor                                                                                        -4.78         1.38
  ENDOG         Endonuclease G                                                                                                          -11.37        1.06
  ERBB3         Receptor tyrosine-protein kinase erbB-3 (ErbB-3; HER3; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3)          -2.29         1.54
  FADD          Fas-associated protein with death domain (MORT1)                                                                        -1.48         -1.42
  FasL          Fas ligand (FAS L, CD95L; CD178; TNFSF6)                                                                                -1.14         7.53
  Fas           Fas receptor (ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6)                                                          -1.23         3.26
  IFN-α2        Interferon alpha-2                                                                                                       1.13         1.54
  IFN-β1        Interferon beta                                                                                                          5.22         1.47
  IGF1          Insulin-like growth factor 1 (IGF-I; IGF1A; IGFI)                                                                       -1.14         -1.15
  IGF1 R        Insulin-like Growth Factor 1 (IGF-1), Receptor (CD221; IGFIR; IGFR; JTK13)                                              -3.50         1.27
  IKBKB         inhibitor of nuclear factor kappa-B kinase subunit beta (IKK-beta; IKK2; IKKB; NF-κBIKB)                                -3.52         1.33
  IKBKG         inhibitor of nuclear factor kappa-B kinase subunit gamma (AMCBX1; FIP3; IKK-gamma; IP1; IP2; IPD2; NEMO)                -5.76         1.40
  IL-10         Interleukin 10                                                                                                           1.10         12.15
  IL-1α         Interleukin-1 alpha                                                                                                     -2.60         1.64
  IL-1β         Interleukin-1 beta                                                                                                      -2.20         1.30
  IL-2          Interleukin 2                                                                                                            1.24         12.15
  IL-4          Interleukin 4                                                                                                           -3.72         2.39
  IL-6R         Interleukin 6 receptor (CD126)                                                                                          -5.80         1.92
  IL-7          Interleukin 7                                                                                                           -1.65         1.26
  IRAK1         Interleukin-1 receptor-associated kinase 1                                                                              -3.70         3.39
  JAK2          Janus kinase 2 (JTK10; THCYT3)                                                                                           1.06         -1.21
  MAP3K1        Mitogen-activated protein kinase kinase kinase 1 (MAPKKK1; MEKK; MEKK 1; MEKK1; SRXY6)                                  -4.55         1.51
  MAP3K5        Mitogen-activated protein kinase kinase kinase 5 (ASK1; MAPKKK5; MEKK5)                                                 -2.39         1.99
  MAP2K4        Mitogen-activated protein kinase kinase 4 (JNKK1; MAPKK4; MEK4)                                                         -1.06         2.54
  MAP2K7        Mitogen-activated protein kinase kinase 7(MAPKK7; MEK7)                                                                 -1.09         3.05
  MAPK1         Mitogen-activated protein kinase 1 (ERK; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41)                       -2.21         1.00
  MAPK3         Mitogen-activated protein kinase 3(ERK1; HS44KDAP; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK)                         -2.74         1.67
  MAPK8         Mitogen-activated protein kinase 8(JNK; JNK1; SAPK1)                                                                     1.73         2.53
  MAPK9         Mitogen-activated protein kinase 9(JNK2; JNK2A; JNK2B; SAPK)                                                             1.02         2.25
  MYD88         Myeloid differentiation primary response gene (88)                                                                      -6.09         1.82
  NF-κB1        Nuclear factor NF-kappa-B p105 subunit(NFKB-p105; NFKB-p50; NFkappaB; p105; p50)                                        -4.81         1.18
  NF-κB3        Transcription factor p65 (RELA; NF-κB p65)                                                                              -1.35         2.63
  NF-κBIA       Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IKBA; MAD-3; NFKBI)                 1.49         2.96
  NTRK1         Neurotrophic tyrosine kinase receptor type 1(MTC; TRK; TRK1; TRKA; Trk-A; p140-TrkA)                                    -2.84         1.33
  PDCD1         Programmed cell death protein 1( CD279; PD-1; hPD-l)                                                                    -1.63         4.48
  PDCD4         Programmed cell death protein 4                                                                                         -1.30         1.06
  PDCD 7        Programmed cell death protein 7                                                                                          1.87         1.42
  PI3K-α        Phosphoinositide-3-kinase, catalytic, alpha polypeptide(PIK3CA; p110-alpha; PI3K)                                       -1.26         1.04
  PI3K-γ        Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PIK3CG ; PI3K; PI3Kgamma; PIK3)         -1.40         5.18
  PIK3R2        Phosphatidylinositol 3-kinase regulatory subunit beta(P85B; p85; p85-BETA)                                              -2.12         -1.20
  PPP3R1        protein phosphatase 2B regulatory subunit 1(CALNB1; CNB; CNB1)                                                          -1.52         1.94
  RIPK1         Receptor-interacting serine/threonine-protein kinase 1(RIP; RIP1)                                                       -2.44         1.24
  STAT1         Signal transducers and activators of transcription (CANDF7; ISGF-3; STAT91)                                             -6.18         4.04
  STAT5A        Signal transducer and activator of transcription 5A                                                                     -1.14         -1.15
  STAT5B        Signal transducer and activator of transcription 5B                                                                     -3.17         1.08
  TGFB1         Transforming growth factor beta 1(CED; DPD1; LAP; TGFB; TGFbeta)                                                        -2.23         -1.15
  TNF-α         Tumor necrosis factors                                                                                                  -1.97         2.19
  TNFRSF10A     Tumor necrosis factor receptor superfamily member 10A (APO2; CD261; DR4; TRAILR-1; TRAILR1)                             -2.82         2.03
  TNFRSF10B     Tumor necrosis factor receptor superfamily member 10B (DR5, CD262, TRICK2, TRICKB, TRAILR2, TRICK2A, TRICK2B)           -2.84         1.02
  P53           Tumor protein 53(LFS1; TP53; TRP53)                                                                                     -7.60         1.32
  XIAP          X-linked inhibitor of apoptosis protein(API3; BIRC4; IAP-3; ILP1; MIHA; XLP2; hIAP3)                                    -1.94         2.59

Negative values indicate down-regulation of genes.

EV71 induced activation of death receptor signal pathway
--------------------------------------------------------

When RD cells were infected with EV71 at 20 h, the expressions of caspase -10, -8, -7, -3 and FasL were highly elevated. Upon death ligand-receptor binding, caspase-10 is coupled to the multimeric Fas/TNF receptor complex via DED/FADD adaptor interaction. This complex may process procaspase-10 and -8 into a large active subunit and a small subunit. Then cleaved caspase-10 and -8 can further process other caspase members, including caspase-7 and -3, to initiate a caspase cascade, leading to programmed cell death. Interestingly, the gene expressions of CD40L, MEK4, MEK7 and c-Fos were induced by 5.44, 2.54, 3.05 and 3.23 fold in RD cells at 20 h posinfection. In addition, JNK1/2, NF-κB p65 and c-Jun were significantly activated and phosphorylated (Figure [7](#F7){ref-type="fig"}). Based on these results, putative pathways of apoptosis were predicted for EV71-infected RD cells (Figure [8](#F8){ref-type="fig"}).

![**EV71 infection induced activation of apoptotic signal pathway proteins.** Cell lysates were prepared from EV71-infected RD cells at the indicated time and resolved with 12% SDS-PAGE. Proteins were transferred onto PVDF membranes and subjected to western blotting. (**A**) FasL expression in EV71- infected RD cells at 0, 8, and 20 h. (**B**) Western blot analysis for caspase-10, -8, -7, and -3 in EV71- infected RD cells at 0, 3, 8, 20 and 24 h. GAPDH was probed as the loading control. The phosphorylated or total proteins of AKT2 (**C**), JNK1/2 (**D**), NF-κB (**E**) and c-Jun (**F**) were detected by western blotting at 0, 8, and 20 h. The amounts of β-actin were also assessed to monitor the equal loadings of protein extracts.](1471-2334-12-327-7){#F7}

![**Putative apoptotic pathways in EV71-infected RD cells.** The pathways were deduced from PCR array and western blotting analysis.](1471-2334-12-327-8){#F8}

Discussion
==========

Apoptosis is characterized by DNA fragmentation, chromatin condensation, membrane blebbing, cell shrinkage and cell death. An increasing number of viruses can induce apoptosis at the late stage of infection. This process may be important for the spread of progeny viruses to the neighbor cells and for the protection of progeny viruses against host enzymes and antibodies. There are three major apoptotic pathways including death receptor (extrinsic), mitochondrial (intrinsic) and endoplasmic reticulum pathways, respectively. All of these pathways are observed in the cytoplasm \[[@B21],[@B22]\]. The mechanisms of host defense can limit virus replication, enable infected cells apoptosis, release and exclude immature virus particles through lysosome or proteases. However, the viruses survive through a variety of ways which can interfere with the apoptosis of infected cells to evade or delay the early onset of apoptosis \[[@B16],[@B23]\].

In order to confirm the pathophysiology of EV71 infection and host cellular responses, especially for apoptotic responses, we have employed PCR to analyze the expression changes of cellular genes during the infection process. The expression profiles of 84 pro- and anti-apoptotic genes revealed a significant difference in various time points. With the onset of EV71 replication, the genes such as ACIN1, Akt, APAF1, caspase, CIDEB, DAPK, NF-κB1, STAT1 and p53 associated with apoptosis were interrupted at 8 h postinfection by apoptosis-suppressing effect of EV71. Although many RNA viruses do not encode anti-apoptotic genes, the apoptosis-suppressing mechanisms are still unclear. EV71 infection at 20 h postinfection could stimulate the up-regulation of genes such as FasL, CD40L, TNF-α, TNFRSF10A (DR4), Fas, caspase-10, -8, -7, -3 and XIAP involved in TNFR1 pathway in RD cells. FasL is a type II membrane protein in the TNF-α receptor family and Fas receptor binding with FasL can induce cell apoptosis \[[@B18],[@B24]\]. Interestingly, the expressions of Fas, FasL and DR4 revealed an enhancement by 3.26, 7.53 and 2.03 fold in RD cells at 20 h postinfection, suggesting that the proteins involved in Fas receptor-mediated pathway were activated in EV71-infected RD cells. Furthermore, downstream proteins in the Fas pathway such as caspase-10, -8, -7, -3 and CIDEB were also significantly up-regulated. The activation of TNFR1, CD95 and DR4/DR5 by TNF-α, FasL and TRAIL can trigger the activation of caspase-10, -8, -7, and -3 involved in cell death. The activated caspase-3 can cleave its substrates such as CIDE-B to trigger chromosomal DNA fragmentation. However, the expressions of caspase-12, -9, Bcl-2, and APAF1 were unchanged in EV71-infected cells. Previous studies reported that the death receptor pathway for apoptosis was the major pathway during the EV71 infection of RD cells \[[@B22],[@B25]\]. In this study, differential changes of apoptotic gene expressions may be attributed to different conditions such as MOI, infection duration and EV71 strains.

CD40L is described originally in T lymphocytes. However, its expression has been observed in a wide variety of cells including platelets, mast cells, macrophages, basophils, NK cells, B lymphocytes as well as non-haematopoietic cells \[[@B26]\]. As a member of the TNF-α receptor family, CD40 relies on interaction with TRAF proteins to mediate an intracellular signal in response to CD40L binding \[[@B27],[@B28]\]. The downstream protein of TRAF2/3 can activate consecutive initiation of MEK4 and MEK7, resulting in the activation of stress-activated protein kinases JNK1/2 \[[@B29]\]. Subsequently, transcription factor activator of proteins (c-Fos and c-Jun) and NF-κB were activated through a kinase pathway involving in map kinases, NIK (NF-κB inducing kinase) and I-κB kinase, thus co-stimulating the proliferation of activated T-cells accompanied by the production of IFN-γ, TNF-α, and IL-2 \[[@B28]\]. Interestingly, the expressions of CD40L, MEK4 and MEK7 were induced by 5.44, 2.54, and 3.05-fold in RD cells at 20 h postinfection, whereas JNK1/2 was highly phosphorylated. Therefore, we postulated that CD40L/CD40 signaling pathway was also activated in EV71-infected RD cells.

The serine/threonine kinase AKT, also known as protein kinase B (PKB), has become a major focus because of its critical regulatory role in cellular processes including cancer progression \[[@B30]\]. AKT cascades are activated by receptor tyrosine kinases, integrins, B- and T-cell receptors, cytokine receptors, G-protein coupled receptors and other stimuli for inducing the accumulation of phosphatidylinositol 3,4,5-triphosphates by phosphoinositide 3-kinase (PI3K) \[[@B31]\]. Three AKT isoforms (AKT1, AKT2 and AKT3) can mediate many downstream events regulated by PI3K. At 8 h postinfection, the expression of AKT2 was significantly down-regulated by 3.36 fold, while PI3K and AKT2 were enhanced by 5.18 fold and 2.66 fold at 20 h postinfection, respectively. The phosphorylation of AKT2 was highly elevated. As previously reported, EV71 can activate PI3K/AKT to trigger the anti-apoptotic pathways at the early phase during infection \[[@B32],[@B33]\]. In this study, the activation of PI3K/AKT may be associated with EV71 strain virulence and virus titer.

Transcription factor NF-κB p65 (NF-κB3) is a protein encoded *RELA* gene in human. Activated NF-κB p65 translocates into the nucleus and binds DNA at kappa-B-binding motifs, thus being involved in the production of cytokines including IL-2, IL-6, TNF-α, IFN-β and IL-1β \[[@B34],[@B35]\]. While STAT1 is a member of the signal transducers and activators of transcription family and involved in the up-regulation of the genes through type I, type II or type III interferon \[[@B36]\]. Both NF-κB and STAT1 are rapidly activated in response to various stimuli including viral infection and cytokines, thus controlling the expressions of anti-apoptotic, pro-proliferative and immune response genes. In this study, NF-κB p65 and STAT1 were upregulated by 2.63 and 4.04 fold, respectively. Meanwhile, NF-κB p65 was significantly phosphorylated at 20 h postinfection. However, NF-κBIA was up-regulated by 2.96 fold, which can block NF-κB to bind to DNA. IL-2, IL-4, IL-10 and TNF-α exhibited the enhancement by 12.15, 2.39, 12.15 and 2.19 fold at 20 h after EV71 infection. Compared with EV71-uninfected controls, the expression levels of IL-4, IL-10 and TNF-α in EV71-infected RD cells revealed a significant increase at 20 and 32 h postinfection (*P* \< 0.01,or *P* \< 0.001).

Eight human IAPs such as NAIP (BIRC1), c-IAP1 (BIRC2), c-IAP2 (BIRC3), X-linked IAP (XIAP, BIRC4), Survivin (BIRC5), Apollon (BRUCE, BIRC6), Livin/ML-IAP (BIRC7) and IAP-like protein 2 (BIRC8) have been identified \[[@B37],[@B38]\]. BIRC3 can participate in TNF-α-mediated NF-κB activation, while XIAP can bind to the active site of effector caspases including caspase-3, caspase-7 and caspase-9 for preventing substrate binding and subsequent catalysis through its BIR2 domain with N-terminal linker \[[@B39]\]. BIRC3 and XIAP were significantly up-regulated by 3.19 fold and 2.59 fold at 20 h postinfection, which may be related to the apoptosis inhibition of RD cells. Additionally, the up-regulation of CD5, CD24, CD70, CD226 and PDCD1 (PD-1) that usually express on the surface of T cells, B cells, dendritic cells, NK cells, and tumor cells have also been observed \[[@B40]-[@B44]\]. Interestingly, these genes revealed a significant up-regulation in EV71-infected RD cells and may be associated with cell signal pathway and apoptosis. Therefore, further study is needed to be undertaken for these gene expressions.

Conclusions
===========

PCR array is an effective method to analyze differential gene expressions on cellular signaling pathways. The results showed that RD cells have a general trend to inhibit cell proliferation and delay the apoptotic process during the early stage of EV71 infection. EV71 induced-apoptosis may be associated with the activation of Fas, CD40 and TNF death receptor as well as the cleavage of initiator caspases including caspase-10 and -8. However, the activation of caspase-12, -9 and APAF1 in mitochondrial apoptotic pathway and endoplasmic reticulum stress was not completed in EV71-infected RD cells, which may be associated with MOI, infection duration and EV71 strains, etc. In response to EV71 infection, both NF-κB and c-Jun are activated to translocate into the nucleus to induce the production of IL-4, IL-10 and TNF-α. Thus, our findings will provide a theoretical evidence for reducing cell damage and intervening EV71 infection process.
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